ASX 200 gives up rally to finish Thursday’s session flat
The ASX 200 benchmark finished flat on Thursday, following two sessions where energy and healthcare stocks swapped roles.
Late rally, then late slide
ASX 200 shares continued to be dominated by oil price new as Brent crude’s rebound back above US$20 brought some risk appetite back into the market.
But it was another topsy-turvy affair with the energy and healthcare sectors swapping roles as lifters and draggers.
The benchmark ASX 200 started Wednesday’s session having lost along 5% across the previous two sessions. Early on, it looked like more of the same with the ASX 200 down 2.3%.
But then a rally started that had the index in modestly positive territory for a moment, before finishing Wednesday’s session flat at 5,221.20 points.
On Thursday, the reverse happened. Positive momentum had the ASX 200 up over 1%, before the bears took over to bring the index back to 5,217.10 points, down less than 0.1%.
On the economic data front, there was the Commonwealth Bank’s Purchasing Manager’s Index which showed a collapse in the services sector - more than expected and to a greater extent that manufacturing.
Wednesday’s heroes are Thursday’s villains
In spite of all this, all the attention was on energy. Santos, Australia’s second largest independent gas producer, surged 7.2% on Thursday after telling investors it was in a financial position to ride out the oil price crash.
The energy giant reported its first quarter results, which included a ‘strong’ operational performance with US$265 million (A$420.7 million) of free cash flow.
‘The current environment is a time for discipline,’ said Santos chief executive Kevin Gallagher, who has targeted a breakeven oil price for free cash flow of just US$25 a barrel.
Santos finished Thursday’s session at $4.28, up 6.2% thanks to Thursday’s rally. The rest of the energy sector was helped with Woodside Petroleum finishing up 0.3% to $19.97 and Oil Search flat at $2.49.
Beach Energy, which was one of the worst performers on Wednesday after its quarterly update, finished at $1.32, up 1.9% for the day.
Lynas, the world's largest rare earths miner outside China, rocketed on Thursday after telling the market the US military would give it initial funding for a heavy rare earths separation facility in Texas. Lynas ended Thursday’s session at $1.64, up 11.9% since Tuesday’s close.
A2 Milk continued to trade around all-time highs after telling the market to expect revenue of NZD$1.7-NZD$1.75 billion for full-year 2020 with earnings margins to lift to 31-32%. A2 has benefited from stockpiling amid the coronavirus. It’s shares finished Thursday at $18.60.
The ASX 200 may have been able to hold its early gains on Thursday had it not been for the healthcare shares that dragged the index into the red. On Wednesday it was the reverse.
Blood plasma heavyweight CSL lost ground late in the session. The healthcare giant lost 0.9% from Tuesday’s close to finish at $304.77.
Meanwhile, Ramsay Health Care lost 6.1% to close $60.59 after launching a $1.2 billion capital raise.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Seize a share opportunity today
Go long or short on thousands of international stocks.
- Increase your market exposure with leverage
- Get spreads from just 0.1% on major global shares
- Trade CFDs straight into order books with direct market access
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.